Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB-DYYB Cause Lung opacity? 6 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Lung opacity have been filed in association with INFLIXIMAB-DYYB (ZYMFENTRA). This represents 0.0% of all adverse event reports for INFLIXIMAB-DYYB.

6
Reports of Lung opacity with INFLIXIMAB-DYYB
0.0%
of all INFLIXIMAB-DYYB reports
0
Deaths
1
Hospitalizations

How Dangerous Is Lung opacity From INFLIXIMAB-DYYB?

Of the 6 reports, 1 (16.7%) required hospitalization, and 1 (16.7%) were considered life-threatening.

Is Lung opacity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB-DYYB. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB-DYYB Cause?

Off label use (14,256) Condition aggravated (10,275) Intentional product use issue (7,549) Inappropriate schedule of product administration (5,977) Arthralgia (4,615) Drug ineffective (3,112) Fatigue (3,111) Weight increased (2,848) Malaise (2,766) Weight decreased (2,703)

What Other Drugs Cause Lung opacity?

ALBUTEROL (296) PREDNISONE (216) TIOTROPIUM (196) LANSOPRAZOLE (166) IPRATROPIUM (157) ACETAMINOPHEN (153) MEPOLIZUMAB (149) PANTOPRAZOLE (140) BUDESONIDE\FORMOTEROL (139) MONTELUKAST (137)

Which INFLIXIMAB-DYYB Alternatives Have Lower Lung opacity Risk?

INFLIXIMAB-DYYB vs INFLIXIMAB-QBTX INFLIXIMAB-DYYB vs INFLIXIMAB, RECOMBINANT INFLIXIMAB-DYYB vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B

Related Pages

INFLIXIMAB-DYYB Full Profile All Lung opacity Reports All Drugs Causing Lung opacity INFLIXIMAB-DYYB Demographics